Effects of the Number of Neoadjuvant Cycles and Addition of Adjuvant Chemotherapy on the Prognosis of Muscle‐Invasive Bladder Cancer Treated With Radical Cystectomy
Our findings showed that three or more NAC cycles and the addition of AC may have limited effects on OS in MIBC patients who received RC.
Authors
- Motohiro Taguchi
- Naotaka Nishiyama
- Taketo Kawai (ORCID: https://orcid.org/0000-0002-7279-2874)
- Sho Sekito (ORCID: https://orcid.org/0000-0002-7918-2403)
- Shingo Hatakeyama (ORCID: https://orcid.org/0000-0002-0026-4079)
- Tomokazu Sazuka (ORCID: https://orcid.org/0000-0002-8902-7853)
- Fumihiko Urabe (ORCID: https://orcid.org/0000-0002-2599-8183)
- Keiji Yasue (ORCID: https://orcid.org/0000-0003-3129-5721)
- Hiroshi Kitamura (ORCID: https://orcid.org/0000-0001-9643-3211)
- Wataru Fukuokaya (ORCID: https://orcid.org/0000-0003-1044-912X)
- Yoshiyuki Matsui (ORCID: https://orcid.org/0000-0002-2953-7085)
- Shuichi Tatarano (ORCID: https://orcid.org/0000-0003-4224-5084)
- Jun Miki (ORCID: https://orcid.org/0000-0002-4638-8640)
- Katsuyoshi Hashine (ORCID: https://orcid.org/0000-0002-3031-7258)
- Takeshi Sano
- Kenichiro Shiga
- Yusuke Sugino (ORCID: https://orcid.org/0000-0001-8361-0805)
- Rikiya Taoka (ORCID: https://orcid.org/0000-0003-3243-499X)
- Takuji Hayashi (ORCID: https://orcid.org/0000-0003-2030-3087)
- Koichiro Wada (ORCID: https://orcid.org/0000-0001-8316-2192)
- Junichi Inokuchi (ORCID: https://orcid.org/0000-0002-6791-905X)
- Hiroaki Matsumoto (ORCID: https://orcid.org/0000-0003-0568-1258)
- Soki Kashima (ORCID: https://orcid.org/0000-0003-4536-3449)
- Makito Miyake (ORCID: https://orcid.org/0000-0001-9503-7356)
- Kiyoaki Nishihara (ORCID: https://orcid.org/0000-0002-1298-3273)
- Yuto Matsushita (ORCID: https://orcid.org/0000-0002-8159-9793)
- Yoji Murakami
- Ryoichi Saito (ORCID: https://orcid.org/0000-0002-3163-8723)
- Hirohito Naito (ORCID: https://orcid.org/0000-0002-1045-1978)
- Noriya Yamaguchi
- Shotaro Nakanishi (ORCID: https://orcid.org/0000-0002-0117-9490)
- Kei Daizumoto (ORCID: https://orcid.org/0009-0004-9007-435X)
- Chikara Οhyama (ORCID: https://orcid.org/0000-0003-1550-8379)
- Takashige Abe (ORCID: https://orcid.org/0000-0002-5468-7632)
- Ayumu Matsuda
- Minoru Kato (ORCID: https://orcid.org/0000-0002-4171-6027)
- Takashi Kawahara (ORCID: https://orcid.org/0000-0001-6494-819X)
- Masato Fujii
- Ryo Maruyama
Institutions
- Kurume University (JP)
- Kagoshima University (JP)
- Jikei University School of Medicine (JP)
- University of Miyazaki (JP)
- Kansai Medical University (JP)
- Kyushu University (JP)
- University of Tsukuba (JP)
- Hirosaki University (JP)
- Chiba University (JP)
- Shimane University (JP)
- Yamaguchi University (JP)
- Mie University (JP)
- Kagawa University (JP)
- Akita University (JP)
- Hokkaido University (JP)
- Kyoto University (JP)
- Hamamatsu University School of Medicine (JP)
- University of the Ryukyus (JP)
- Kurashiki Central Hospital (JP)
- Katsushika Medical Center (JP)
- The Jikei University Hospital (JP)
- Aichi Cancer Center (JP)
- Jikei University Kashiwa hospital (JP)
- Shikoku Cancer Center (JP)
- Harasanshin Hospital (JP)
- Osaka International Cancer Institute (JP)
- Tokyo National Hospital (JP)
- University of Toyama (JP)
- Osaka Metropolitan University (JP)
- Tottori University (JP)
- Nara Medical University (JP)
- Tokyo Metropolitan University (JP)
- Niigata University (JP)
- The University of Tokyo (JP)
- Hyogo University (JP)
- Teikyo University (JP)
- Tokushima University (JP)
- Kumamoto University (JP)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2025-04-29
- DOI
- https://doi.org/10.1002/cam4.70782
- Citations
- 4
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 8.03
Funders
- Japan Society for the Promotion of Science